Abstract
Introduction/BackgroundIn March 2019, interval cytoreductive surgery (ICS) with hyperthermic intraperitoneal chemotherapy (HIPEC) became the standard of care for FIGO stage III ovarian cancer patients treated with neo-adjuvant chemotherapy in the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
